Unstable angina / non ST elevation myocardial infarction drug and substance abusers: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{WikiDoc Cardiology Network Infobox}}
{{WikiDoc Cardiology Network Infobox}}
{{CMG}}
{{CMG}}
'''Associate Editor-In-Chief:''' Smita Kohli, M.D.


{{Editor Join}}
{{Editor Join}}

Revision as of 18:50, 14 December 2009

WikiDoc Resources for Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Articles

Most recent articles on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Most cited articles on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Review articles on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Articles on Unstable angina / non ST elevation myocardial infarction drug and substance abusers in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Images of Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Photos of Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Podcasts & MP3s on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Videos on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Evidence Based Medicine

Cochrane Collaboration on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Bandolier on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

TRIP on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Clinical Trials

Ongoing Trials on Unstable angina / non ST elevation myocardial infarction drug and substance abusers at Clinical Trials.gov

Trial results on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Clinical Trials on Unstable angina / non ST elevation myocardial infarction drug and substance abusers at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

NICE Guidance on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

NHS PRODIGY Guidance

FDA on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

CDC on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Books

Books on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

News

Unstable angina / non ST elevation myocardial infarction drug and substance abusers in the news

Be alerted to news on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

News trends on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Commentary

Blogs on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Definitions

Definitions of Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Patient Resources / Community

Patient resources on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Discussion groups on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Patient Handouts on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Directions to Hospitals Treating Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Risk calculators and risk factors for Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Healthcare Provider Resources

Symptoms of Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Causes & Risk Factors for Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Diagnostic studies for Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Treatment of Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Continuing Medical Education (CME)

CME Programs on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

International

Unstable angina / non ST elevation myocardial infarction drug and substance abusers en Espanol

Unstable angina / non ST elevation myocardial infarction drug and substance abusers en Francais

Business

Unstable angina / non ST elevation myocardial infarction drug and substance abusers in the Marketplace

Patents on Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Experimental / Informatics

List of terms related to Unstable angina / non ST elevation myocardial infarction drug and substance abusers

Cardiology Network

Discuss Unstable angina / non ST elevation myocardial infarction drug and substance abusers further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Smita Kohli, M.D.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview of Drug and Substance Abusers with UA / NSTEMI

Cocaine and methamphetamine are common drugs associated with MI.

Cocaine

Cocaine usage can produce myocardial ischemia leading to UA/NSTEMI. Cocaine blocks the presynaptic reuptake of neurotransmitters such as norepinephrine and dopamine, which produces excess concentrations at the postsynaptic receptors that lead to sympathetic activation with consequent vasoconstriction, an acute rise in arterial pressure, tachycardia, and a predisposition to ventricular arrhythmias and seizures. There may also be a direct contractile effect on vascular smooth muscle. Cocaine usage can also predispose to coronary thrombosis as a consequence of coronary spasm. Moreover, cocaine increases the response of platelets to arachidonic acid, thus increasing thromboxane A2 production and platelet aggregation and thus predisposing to cocaine related arterial thrombosis. Cocaine also causes sinus tachycardia, as well as an increase in blood pressure and myocardial contractility, thereby increasing myocardial oxygen demand. These increases can precipitate myocardial ischemia and UA/NSTEMI in both the presence and absence of obstructive coronary atherosclerosis and coronary spasm.

Typical patient with cocaine related chest pain, unstable angina or MI is young(usually less than 40 yrs), of male gender, cigarette smoker, has symptom onset minutes or even several hours after cocaine use. It can occur with all routes of administration and with small or large doses.

Treatment includes nitroglycerin and calcium channel blockers. If patients have STEMI and show no response to sublingual NTG and calcium channel blockers, immediate coronary angiography should be performed, if possible. PCI has been successfully performed in these patients but can problematic in subjects with cocaine-related MI since those in whom stents are deployed are at substantial risk of subsequent in-stent thrombosis unless double-antiplatelet therapy (ASA and clopidogrel) is ingested regularly and predictably for several months afterward, and those who partake in substance abuse often are unreliable in adhering to such a regimen. Beta blockers should not be used in patients with cocaine induced MI as it can augment cocaine induced coronary arterial vasoconstriction. In order to control sinus tachycardia and hypertension(after initial NTG and calcium channel blockers), labetalol, an alpha and beta blocker, has been advocated, because it has been shown not to induce coronary artery vasoconstriction.

Methamphetamine

Rapid increase in methamphetamine abuse has also led to increase incidence of patients presenting with methamphetamine induced myocardial ischemia. However, there is not sufficient evidence base for the management of this condition. On the basis of similarities in pathophysiology seen in few case report series, current treatment recommendation is similar to that of cocaine induced MI.


ACC / AHA Guidelines (DO NOT EDIT) [1]

Class I

1. Administration of sublingual or intravenous NTG and intravenous or oral calcium antagonists is recommended for patients with ST segment elevation or depression that accompanies ischemic chest discomfort after cocaine use. (Level of Evidence: C)

2. Immediate coronary angiography, if possible, should be performed in patients with ischemic chest discomfort after cocaine use whose ST segments remain elevated after NTG and calcium antagonists; PCI is recommended if occlusive thrombus is detected. (Level of Evidence: C)

3. Fibrinolytic therapy is useful in patients with ischemic chest discomfort after cocaine use if ST segments remain elevated despite NTG and calcium antagonists, if there are no contraindications, and if coronary angiography is not possible. (Level of Evidence: C)

Class IIa

1. Administration of NTG or oral calcium channel blockers can be beneficial for patients with normal ECGs or minimal ST segment deviation suggestive of ischemia after cocaine use. (Level of Evidence: C)

2. Coronary angiography, if available, is probably recommended for patients with ischemic chest discomfort after cocaine use with ST-segment depression or isolated T wave changes not known to be previously present and who are unresponsive to NTG and calcium antagonists. (Level of Evidence: C)

3. Management of UA / NSTEMI patients with methamphetamine use similar to that of patients with cocaine use is reasonable. (Level of Evidence: C)

Class IIb

1. Administration of combined alpha and beta blocking agents (e.g., labetalol) may be reasonable for patients after cocaine use with hypertension (systolic blood pressure >150 mm Hg) or those with sinus tachycardia (pulse >100 bpm) provided that the patient has received a vasodilator, such as NTG or a calcium antagonist, within close temporal proximity (i.e., within the previous hour). (Level of Evidence: C)

Class III

1. Coronary angiography is not recommended in patients with chest pain after cocaine use without ST segment or T wave changes and with a negative stress test and cardiac biomarkers. (Level of Evidence: C)

See Also

Sources

  • The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [1]

References

  1. 1.0 1.1 Anderson JL, Adams CD, Antman EM; et al. (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". JACC. 50 (7): e1–e157. PMID 17692738. Text "doi:10.1016/j.jacc.2007.02.013 " ignored (help); Unknown parameter |month= ignored (help)

Template:SIB

Template:WH Template:WS